African mango,
does it really help with Weight and body fat?
research showsAfrican mango has statistical reduction signals for weight and waist circumference in the IGOB131 300 mg RCT and a 2013 review. However, the evidence has major limitations of small samples, short duration, and dose heterogeneity, and all positive studies are tied to the same author group, making it difficult to raise it to B under methodology ②-b. The limitation of studies on a specific extract is central.
ads claimAdvertisements mention "African mango," "appetite," "body fat," and "waist circumference." The research evidence is tied to specific seed extracts and short-term studies.
Useful facts when choosing a product
- Specific extracts such as IGOB131 are not the same as ordinary mango fruit or seed powder.
- Reported adverse effects include headache, gas, and sleep difficulty.
- Because it may affect blood glucose and lipids, people taking diabetes or lipid medications need separate checking.
- Combination-product studies are difficult to separate as effects of Irvingia alone.
What the research actually shows
Ngondi 2005 administered Irvingia gabonensis seed for 4 weeks to 40 adults with obesity and reported reductions in weight and lipids. Oben 2008 reported reductions in weight, body fat, and waist circumference over 10 weeks in a 72-person study of a Cissus quadrangularis/Irvingia gabonensis combination product, but it was a combination product. The IGOB131 300 mg study and the 2013 systematic review summarize statistical weight-loss signals, but the included studies are small, short-term, highly heterogeneous in dose, and all concentrated in the same author group. It is difficult to extend results from studies of a specific extract to all African mango products in general.
Why this is classified as C (44)
The IGOB131 300 mg RCT and the 2013 review show statistical reduction, but small samples, short duration, dose heterogeneity, and same-author-group limitations prevent B under methodology ②-b; this is C at 44 points.
Counterpoint. The larger the reported weight change in a small study, the more important independent replication becomes.
Rejudgment record. Draft — The IGOB131 300 mg RCT and 2013 review show statistical reductions, but small samples, short duration, dose heterogeneity, and same-author-group limitations prevent B under methodology ②-b
Cross-check — Codex and Claude
Evidence Table
| Study | Design | Sample | Funding | Endpoint | Result | Weight |
|---|---|---|---|---|---|---|
| Ngondi JL et al. 2005 | Randomized double-blind placebo-controlled trial | 40 | Academic/unclear | Weight and lipids | Reported reductions in weight and lipids after administration of Irvingia gabonensis seed. | Core |
| Oben JE et al. 2008 | Randomized double-blind placebo-controlled trial | 72 | Gateway Health Alliances supplied materials | Weight, body fat, and waist circumference | Reported body-composition improvement with a Cissus/Irvingia combination product. | Supporting |
| Onakpoya IJ et al. 2013 | Systematic review | Academic | Weight loss | Assessed that there were potential signals, but the data were limited and quality issues were present. | Core |
Receipt — 3 References
Every cited source was opened and checked against the live page on 2026-07-10.
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-07-10 · Corrections: none
Cite this verdict
[Chamgap] African mango x weight and body fat — Evidence Grade C·44. 3 cited sources checked. Source: https://health-receipt.pages.dev/en/verdicts/weight/african-mango-weight-fat/ · CC BY 4.0CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.
What this document does and does not do
Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.